Attached files

file filename
EX-31.2 - EX31_2 - Rich Pharmaceuticals, Inc.ex31_2.htm
EX-32.1 - EX32_1 - Rich Pharmaceuticals, Inc.ex32_1.htm
EX-31.1 - EX31_1 - Rich Pharmaceuticals, Inc.ex31_1.htm
EXCEL - IDEA: XBRL DOCUMENT - Rich Pharmaceuticals, Inc.Financial_Report.xls

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

[X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
   
  For the quarterly period ended June 30, 2013
   
[ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934
   
  For the transition period  to  __________
   
  Commission File Number:000-54767

 

Nepia, Inc.

(Exact name of Registrant as specified in its charter)

 

Nevada 46-3259117
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)
   

9595 Wilshire Blvd., Suite 900

Beverly Hills, California 90212

(Address of principal executive offices)
   
(323) 424-3169
(Registrant’s telephone number)
   
_______________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)
     

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days [X] Yes [ ] No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ ] No [X]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

[ ] Large accelerated filer Accelerated filer [ ] Non-accelerated filer
[X] Smaller reporting company  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [] Yes [ X] No

 

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 993,108 common shares as of August 17, 2013.

1

 

  TABLE OF CONTENTS

 

Page

     
PART I - FINANCIAL INFORMATION
 
Item 1: Financial Statements 3
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations 4
Item 3: Quantitative and Qualitative Disclosures About Market Risk 6
Item 4: Controls and Procedures 6
 
PART II - OTHER INFORMATION
 
Item 1: Legal Proceedings 7
Item 1A: Risk Factors 7
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 7
Item 3: Defaults Upon Senior Securities 7
Item 4: Mine Safety Disclosures 7
Item 5: Other Information 7
Item 6: Exhibits 7

 

2

 

Item 1. Financial Statements

 

Our financial statements included in this Form 10-Q are as follows:

 

 

F-1

Balance Sheets as of June 30, 2013 and March 31, 2013
F-2 Statements of Operations for the three months ended June 30, 2013 and 2012 and the period from August 9, 2010 (date of inception) to June 30, 2013
F-3 Statements of Cash Flows for the three months ended June 30, 2013 and 2012 and the period from August 9, 2010 (date of inception) to June 30, 2013
F-4 – F-9 Notes to Financial Statements

 

These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended June 30, 2013 are not necessarily indicative of the results that can be expected for the full year.

 

3

NEPIA, INC. 

(A DEVELOPMENT STAGE COMPANY)

BALANCE SHEETS (unaudited)

AS OF JUNE 30, 2013 AND MARCH 31, 2013

 

 

   June 30, 2013  March 31, 2013
ASSETS      
Current Assets      
Cash and equivalents  $60,000   $1,588 
           
TOTAL ASSETS  $60,000   $1,588 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
           
Current Liabilities          
Accrued expenses  $8,641   $6,700 
Due to shareholder   16,818    16,818 
Loan payable   60,000    0 
Due to officer   12,000    7,500 
Total Liabilities   97,459    31,018 
           
Stockholders’ Equity (Deficit)          
Common Stock, $.001 par value, 90,000,000 shares authorized, 2,625,000 shares issued and outstanding   2,625    2,625 
Preferred Stock, $.001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding   0    0 
Additional paid-in capital   49,875    49,875 
Deficit accumulated during the development stage   (89,959)   (81,930)
Total Stockholders’ Equity (Deficit)   (37,459)   (29,430)
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)  $60,000   $1,588 

 

See accompanying notes to financial statements.

F-1

NEPIA, INC.

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF OPERATIONS (unaudited)

FOR THE THREE MONTHS ENDED JUNE 30, 2013 AND 2012

FOR THE PERIOD FROM AUGUST 9, 2010 (INCEPTION) TO JUNE 30, 2013

 

 

   Three months ended
June 30, 2013
  Three months ended
June 30, 2012
  Period from
August 9, 2010
(Inception)
to June 30, 2013
          
REVENUES  $0   $0   $0 
                
OPERATING EXPENSES               
    Organization costs   0    0    320 
    Professional fees   8,029    2,000    89,639 
                
TOTAL OPERATING EXPENSES   8,029    2,000    89,959 
                
LOSS FROM OPERATIONS   (8,029)   (2,000)   (89,959)
                
PROVISION FOR INCOME TAXES   0    0    0 
                
NET LOSS  $(8,029)  $(2,000)  $(89,959)
                
NET LOSS PER SHARE: BASIC AND DILUTED  $(0.00)  $(0.00)     
                
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED   2,625,000    2,625,000      

 

See accompanying notes to financial statements.

 

F-2

NEPIA, INC.

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF CASH FLOWS (unaudited)

FOR THE THREE MONTHS ENDED JUNE 30, 2013 AND 2012

FOR THE PERIOD FROM AUGUST 9, 2010 (INCEPTION) TO JUNE 30, 2013

 

 

   Three months ended
June 30, 2013
  Three months ended
June 30, 2012
  Period from
August 9, 2010
(Inception)
to June 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:               
Net loss for the period  $(8,029)  $(2,000)  $(89,959)
Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities               
Changes in operating assets and liabilities:               
Decrease in prepaid expenses   0    0    0 
Increase in accrued expenses   1,941    1,000    8,641 
Net Cash Used by Operating Activities   (6,088)   (1,000)   (81,318)
                
CASH FLOWS FROM FINANCING ACTIVITIES:               
Increase in due to shareholder   0    0    16,818 
Loan proceeds   60,000    0    60,000 
Increase in due to officer   4,500    1,000    12,000 
Proceeds from sale of common stock   0    0    52,500 
Net Cash Provided by Financing Activities   64,500    1,000    141,318 
                
Net Increase in Cash and Cash Equivalents   58,412    0    60,000 
                
Cash and cash equivalents, beginning of period   1,588    12,500    0 
Cash and cash equivalents, end of period  $60,000   $12,500   $60,000 
                
SUPPLEMENTAL CASH FLOW INFORMATION:               
Interest paid  $0   $0      
Income taxes paid  $0   $0      

 

 

See accompanying notes to financial statements.

F-3

NEPIA, INC.

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

JUNE 30, 2013

 

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Business

Nepia, Inc. (“Nepia” and the “Company”) is a development stage company and was incorporated in Nevada on August 9, 2010. The Company plans to develop, manufacture, and sell small boilers aimed at farmers primarily in Southeast Asia.

 

Development Stage Company

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles related to development-stage companies. A development-stage company is one in which planned principal operations have not commenced or if its operations have commenced, and there has been no significant revenues there from.

 

Basis of Presentation

The financial statements of the Company have been prepared using the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America and are presented in U.S. dollars. The Company has adopted a March 31 fiscal year end.

 

Cash and Cash Equivalents

Nepia considers all highly liquid investments with maturities of three months or less to be cash equivalents. At June 30, 2013 and March 31, 2013 the Company had $60,000 and $1,588, respectively, of unrestricted cash that was being held in an escrow account by its outside attorneys, to be used for future business operations.

 

Fair Value of Financial Instruments

Nepia’s financial instruments consist of cash and cash equivalents, prepaid expenses, accrued expenses and amounts due to an officer and shareholder. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.

 

Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

 

Stock-Based Compensation

Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.

 

Basic loss per share

The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the year. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. The Company has not issued any options or warrants or similar securities since inception.

F-4

NEPIA, INC.

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

JUNE 30, 2013

 

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

Revenue Recognition

The Company will recognize revenue when products are fully delivered or services have been provided and collection is reasonably assured.

 

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Recent Accounting Pronouncements

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

 

NOTE 2 – ACCRUED EXPENSES AND DEPOSIT

 

Accrued expenses consisted of the following as of June 30, 2013 and March 31, 2013:

 

   June
30, 2013
  March
31, 2013
Accounting fees  $2,850   $4,500 
Legal fees   4,906    1,365 
Transfer agent fees   885    835 
Total Accrued Expenses  $8,641   $6,700 

 

NOTE 3 – DUE TO SHAREHOLDER

 

A shareholder has loaned the company funds to help support operations. The amounts are unsecured, non-interest bearing and due on demand. The total due to the shareholder was $16,818 as of June 30, 2013 and March 31, 2013.

 

NOTE 4 – LOAN PAYABLE

 

An unrelated third party loaned the company funds during the quarter ended June 30, 2013 to help it expand its operations. The amount is unsecured, non-interest bearing and due on demand. The total loan payable was $60,000 at June 30, 2013.

 

NOTE 5 – DUE TO OFFICER

 

An officer has loaned the company funds to help support operations. The amount is unsecured, non-interest bearing and due on demand. The total due to the officer was $12,000 and $7,500 as of June 30, 2013 and March 31, 2013, respectively.

F-5

NEPIA, INC.

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

JUNE 30, 2013

 

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

Nepia neither owns nor leases any real or personal property. An officer has provided office services without charge. There is no obligation for the officer to continue this arrangement. Such costs are immaterial to the financial statements and accordingly are not reflected herein. The officers and directors are involved in other business activities and most likely will become involved in other business activities in the future.

 

NOTE 7 – CAPITAL STOCK

 

The Company has 90,000,000 common shares authorized with a par value of $ 0.001 per share.

 

The Company has 10,000,000 preferred shares authorized with a par value of $ 0.001 per share.

 

At inception, the Company issued 2,625,000 shares of common stock at $0.02 per share for total cash proceeds of $52,500.

 

There were 2,625,000 shares of common stock issued and outstanding as of June 30, 2013 and March 31, 2013.

 

There were 0 shares of preferred stock issued and outstanding as of June 30, 2013 and March 31, 2013.

 

NOTE 8 – INCOME TAXES

 

As of June 30, 2013, the Company had net operating loss carry forwards of approximately $89,959 that may be available to reduce future years’ taxable income in varying amounts through 2033. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.

 

The provision for Federal income tax consists of the following for the periods ended June 30, 2013 and March 31, 2013:

 

   June
30, 2013
  March
31, 2013
Federal income tax benefit attributable to:          
Current operations  $2,730   $10,659 
Less: valuation allowance   (2,730)   (10,659)
Net provision for Federal income taxes  $0   $0 

 

The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of June 30, 2013 and March 31, 2013:

 

   June
30, 2013
  March
31, 2013
Deferred tax asset attributable to:          
Net operating loss carryover  $30,586   $27,856 
Less: valuation allowance   (30,586)   (27,856)
Net deferred tax asset  $0   $0 

 

F-6

NEPIA, INC.

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

JUNE 30, 2013

 

NOTE 8 – INCOME TAXES (CONTINUED)

 

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $89,959 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur net operating loss carry forwards may be limited as to use in future years.

 

NOTE 9 – LIQUIDITY AND GOING CONCERN

 

Nepia has a working capital deficit, has not yet received revenues from sales of products or services, and has incurred losses since inception. These factors create substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.

 

The ability of Nepia to continue as a going concern is dependent on the Company generating cash from the sale of its common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plans include selling its equity securities and obtaining debt financing to fund its capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.

 

NOTE 10 – SUBSEQUENT EVENTS

 

On July 19, 2013, the company entered into an Agreement of Conveyance, Transfer and Assignment of Assets and Assumption of Obligations (the “Agreement”) with its prior officer and directors, Li Deng Ke and Xiong Chao Jun. Pursuant to the Agreement, the company transferred all assets and business operations associated with our boiler business to Messrs. Ke and Jun. In exchange, Messrs. Ke and Jun agreed to assume and cancel all liabilities relating to the company’s former business, including shareholder and officer loans amounting to $24,318. 

 

On July 18, 2013, the company entered into a Memorandum of Understanding and Asset Assignment Agreement (the “Assignment Agreement”) with Imagic, LLC dba Rich Pharmaceuticals (“Rich Pharmacueticals”) and Richard L. Chang’s Holdings, LLC to acquire certain assets including United States Patent No. 6,063,814 entitled “Phorbol esters as anti-neoplastic and white blood cell elevating agents” and all related intellectual property associated with the patent. In consideration for the newly acquired assets, the company agreed to issue Rich Pharmaceuticals 198,625 shares of its common stock and to issue Ben Chang 6,000,000 of its newly created Series A Preferred Stock with super voting rights. The company further agreed to use its best efforts to complete a financing resulting in proceeds of at least US $2,000,000. If the company is unable to raise $400,000 according to the terms of the Assignment Agreement, the assets revert back to Rich Pharmaceuticals and Richard L. Chang’s Holdings.

 

As part of the Assignment Agreement, Rich Pharmaceuticals and Richard L. Chang’s Holdings shall have the option at any time after November 1, 2013 and before November 1, 2014, to assign to the company any and all interest these companies have in the indication, patents and intellectual property related to Hodgkin’s Lymphoma in consideration for the company issuing to Ben Chang: (i) 476,820 restricted shares of its common stock; and (i) 1.0408 restricted shares of its common stock for each one share of our restricted common stock issued by the company prior to the date which the company receive notice of intent to exercise the option, adjusted for any stock split the company happens to undertake.

F-7

NEPIA, INC.

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

JUNE 30, 2013

 

 

NOTE 10 – SUBSEQUENT EVENTS (CONTINUED)

 

In consequence of the Agreement and Assignment Agreement, Sean Webster resigned in his position as an officer and director with the company. In his stead, Ben Chang was appointed as the company’s President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director.

 

Li Deng Ke and Xiong Chao Jun sold 1,275,000 shares of their common stock in the company to Ben Chang, and Mr. Chang cancelled 1,200,517 of those shares he received and returned them to the company treasury.

 

On July 18, 2013, the company designated from its 10,000,000 authorized shares of preferred stock, par value $0.001 per share, 6,000,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock have super voting rights of 100 votes per share and vote with shares of our common stock as a single class.

 

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to June 30, 2013 to the date these financial statements were issued and has determined that, aside from the items listed above, it does not have any material subsequent events to disclose in these financial statements.

 

F-8

 

Item 2.     Management’s Discussion and Analysis of Financial Condition and Results of Operations 

 

Forward-Looking Statements

 

Certain statements contained in this report on Form 10-Q, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the Securities and Exchange Commission.

 

Company Overview

 

The Company is a development stage company and has not generated any sales to date. During the period covered by this report and through July 18, 2013, the Company had been engaged in the business of developing, manufacturing, and selling straw burning boilers specifically for use as energy-efficient heating systems, as well as for cooking. As the Company was unable to raise the capital necessary to develop and market the heating systems products, the Company sought out new opportunities.

 

On July 18, 2013, the company entered into a Memorandum of Understanding and Asset Assignment Agreement (the “Assignment Agreement”) with Imagic, LLC dba Rich Pharmaceuticals (“Rich Pharmacueticals”) and Richard L. Chang’s Holdings, LLC to acquire certain assets including United States Patent No. 6,063,814 entitled “Phorbol esters as anti-neoplastic and white blood cell elevating agents” and all related intellectual property associated with the patent. In consideration for the newly acquired assets, the company agreed to issue Rich Pharmaceuticals 198,625 shares of its common stock and to issue Ben Chang 6,000,000 of its newly created Series A Preferred Stock with super voting rights. The company further agreed to use its best efforts to complete a financing resulting in proceeds of at least US$2,000,000. If the company is unable to raise $400,000 according to the terms of the Assignment Agreement, the assets revert back to Rich Pharmaceuticals and Richard L. Chang’s Holdings. As part of the Assignment Agreement, Rich Pharmaceuticals and Richard L. Chang’s Holdings shall have the option at any time after November 1, 2013 and before November 1, 2014, to assign to the company any and all interest these companies have in the indication, patents and intellectual property related to Hodgkin’s Lymphoma in consideration for the company issuing to Ben Chang: (i) 476,820 restricted shares of its common stock; and (i) 1.0408 restricted shares of its common stock for each one share of our restricted common stock issued by the company prior to the date which the company receive notice of intent to exercise the option, adjusted for any stock split the company happens to undertake.

4

In consequence of the Agreement and Assignment Agreement, Sean Webster resigned in his position as an officer and director with the company. In his stead, Ben Chang was appointed as the company’s President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director. Li Deng Ke and Xiong Chao Jun sold 1,275,000 shares of their common stock in the company to Ben Chang, and Mr. Chang cancelled 1,200,517 of those shares he received and returned them to the company treasury.

 

On July 18, 2013, the company designated from its 10,000,000 authorized shares of preferred stock, par value $0.001 per share, 6,000,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock have super voting rights of 100 votes per share and vote with shares of our common stock as a single class.

 

On July 19, 2013, the company entered into an Agreement of Conveyance, Transfer and Assignment of Assets and Assumption of Obligations (the “Agreement”) with its prior officer and directors, Li Deng Ke and Xiong Chao Jun. Pursuant to the Agreement, the company transferred all assets and business operations associated with our boiler business to Messrs. Ke and Jun. In exchange, Messrs. Ke and Jun agreed to assume and cancel all liabilities relating to the company’s former business, including shareholder and officer loans amounting to $24,318. 

 

From and after July 18, 2013, the Company is in the business of developing PD-616 for the treatment of Acute Myelogenous Leukemia (AML), and to cause elevation of white blood cells (WBC) in patients depleted of these elements due to various conditions. The Company is no longer engaged in the business of developing, manufacturing, and selling straw burning boilers specifically for use as energy-efficient heating system. A more complete description of the Company’s business is contained under “Item 2.01 Completion of Acquisition or Disposition of Assets” in our Current Report on Form 8-K filed with the SEC on July 24, 2013 (the “Super 8-K). Readers are encouraged to read the Super 8-K to gain a better understanding of the Company business and the risk factors associated with the Company.

 

Results of Operations for the Three Months Ended June 30, 2013 and 2012, and Period from August 9, 2010 (Date of Inception) until June 30, 2013

 

We generated no revenue for the period from August 9, 2010 (Date of Inception) through June 30, 2013. We are a development stage company and do not anticipate earnings revenues until we are able to sell or license our products.

 

Our operating expenses during the three months ended June 30, 2013 were $8,029, as compared with $2,000 for the same period ended 2012. Our operating expenses from August 9, 2010 (Date of Inception) to June 30, 2013 were $89,959. For all periods mentioned, our operating expenses consisted mainly of professional fees.

 

We, therefore, recorded a net loss of $8,029 for the three months ended June 30, 2013 as compared with a net loss of $2,000 for the same period ended 2012. We recorded a net loss of $89,959 for the period from August 9, 2010 (Date of Inception) until June 30, 2013.

 

We anticipate our operating expenses will increase substantially as we undertake our new plan of operations which went into effect on July 18, 2013.

 

Liquidity and Capital Resources

 

As of June 30, 2013, we had total current assets of $60,000. We had total current liabilities of $97,459 as of June 30, 2013. Thus, we had a working capital deficit of $37,459 as of June 30, 2013.

 

Operating activities used $81,318 in cash for the period from August 9, 2010 (Date of Inception) until June 30, 2013. Our net loss of $89,959 primarily accounted for our negative operating cash flow. Financing Activities during the period from August 9, 2010 (Date of Inception) until June 30, 2013 generated $141,318 in cash during the period from the sale of common stock in the amount of $52,500 and loans of $88,818.

 

5

As of June 30, 2013 and the date of this report, we have insufficient cash to operate our business at the current level for the next twelve months and insufficient cash to achieve our business goals. The success of our business plan is contingent upon us obtaining additional financing. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund our capital expenditures, working capital, or other cash requirements. We do not have any formal commitments or arrangements for the sales of stock or the advancement or loan of funds at this time. There can be no assurance that such additional financing will be available to us on acceptable terms, or at all. Our failure to obtain financing would have a material adverse effect on our business.

 

Off Balance Sheet Arrangements

 

As of June 30, 2013, there were no off balance sheet arrangements.

 

Going Concern

 

We have negative working capital and have not yet received revenues from sales of products or services. These factors create substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustment that might be necessary if we are unable to continue as a going concern.

 

Our ability to continue as a going concern is dependent on generating cash from the sale of our common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plans include selling our equity securities and obtaining debt financing to fund our capital requirement and ongoing operations; however, there can be no assurance we will be successful in these efforts.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk 

 

A smaller reporting company is not required to provide the information required by this Item.

 

Item 4.     Controls and Procedures

 

Disclosure Controls and Procedures

 

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of June 30, 2013. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2013, our disclosure controls and procedures were not effective due to the presence of material weaknesses in internal control over financial reporting.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that, as of June 30, 2013, our disclosure controls and procedures were not effective: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines.

 

Remediation Plan to Address the Material Weaknesses in Internal Control over Financial Reporting

 

Our company plans to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we were not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending March 31, 2014: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the three months ended June 30, 2013 that have materially affected, or are reasonable likely to materially affect, our internal control over financial reporting. After the period ending June 30, 2013, the Company appointed a new Chief Executive Officer and Chief Financial Officer who is responsible for our internal control over financial reporting.

6

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not a party to any pending legal proceeding. We are not aware of any pending legal proceeding to which any of our officers, directors, or any beneficial holders of 5% or more of our voting securities are adverse to us or have a material interest adverse to us.

 

Item 1A: Risk Factors

 

The “Risk Factors” contained in “Item 2.01 Completion of Acquisition or Disposition of Assets/Risk Factors” in our Current Report on Form 8-K filed with the SEC on July 24, 2013 (the “Super 8-K) are hereby incorporated by reference herein. Readers are encouraged to read the Super 8-K including those risk factors.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None

 

Item 3. Defaults upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

Exhibit Number Description of Exhibit
31.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101** The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 formatted in Extensible Business Reporting Language (XBRL).

 

**Provided herewith

 

7

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Nepia, Inc.
   
Date: August 19, 2013
   
 

By: /s/ Ben Chang

Ben Chang

Title: Chief Executive Officer and Director

8